Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Belle Health vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

Belle Health

Best for Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
★★★3.8

Starting at $119/mo

Compounded Semaglutide ($119/mo flat-rate)Compounded Tirzepatide ($199/mo flat-rate, 3-month bundle)Flat-rate pricing — no dose-escalation surchargeFive named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
Visit Belle Health
8.7

Vytora Health

Best for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
★★★★4.4

Starting at $150/mo

CompoundedBrand-Name Available (Mounjaro + Zepbound)All 50 States + DCLegitScript Approved
Visit Vytora Health

Side-by-Side Comparison

FeatureBelle HealthVytora Health
Overall Score7.6/108.7/10
Starting Price$119/mo$150/mo
Editorial Rating3.8 ★ /54.4 ★ /5
Features10 features10 features
States Available5051
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA Warnings1 warningNone

Pros & Cons

Belle Health

Pros

  • Five named LegitScript-certified compounding pharmacy partners (Striker, Strive, OptioRx, Enovex, Braun PharmaCare) — strongest pharmacy disclosure in the WLR directory
  • Flat-rate pricing structure ($119/mo semaglutide, $199/mo tirzepatide) does NOT escalate at higher doses
  • Free weekly registered-dietitian sessions included (head dietitian Megan Ostler, MS, RDN)
  • 9-year operating history — founded 2017 by CEO Chase Jardine
  • LegitScript Certified
  • BBB A+ rating (not BBB-accredited)
  • 30,000+ customers claimed
  • All 50 states

Cons

  • FDA Warning Letter dated 02/20/2026 for misbranding compounded GLP-1 products — recent and serious federal action
  • Tirzepatide $199 price requires 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy partner model — patients may receive different formulations across orders

Vytora Health

Pros

  • All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
  • Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
  • LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
  • Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
  • Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
  • Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
  • Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens

Cons

  • Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
  • Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
  • Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
  • Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
  • Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)

Our Verdict

Winner: Vytora HealthScore: 8.7/10

Vytora Health edges out Belle Health with a higher overall score of 8.7/10 and is particularly strong for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.. Belle Health remains a solid alternative, especially if you're looking for Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring Belle Health and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.